GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Research & Development

Shine-On BioMedical Co (ROCO:6926) Research & Development : NT$81.65 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Shine-On BioMedical Co's Research & Development for the six months ended in Jun. 2024 was NT$47.33 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was NT$81.65 Mil.


Shine-On BioMedical Co Research & Development Historical Data

The historical data trend for Shine-On BioMedical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Research & Development Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - 6.00 6.90 54.24

Shine-On BioMedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial 2.77 4.12 19.92 34.32 47.33

Shine-On BioMedical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$81.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shine-On BioMedical Co  (ROCO:6926) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Shine-On BioMedical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Shine-On BioMedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines